You are here
- Home
- Therapy Areas
- Respiratory/Inflammation
A comparative, placebo-controlled, double blind, double dummy, cross-over, single centre, phase IIIb study between formoterol alone (Oxis Turbuhaler 4.5 µg) and the fixed combination of formoterol and budesonide (Symbicort Turbuhaler 160/4.5 µg) on airway responsiveness and airway inflammation induced by repeated low-dose allergen challenge in allergic patients with mild asthma.
- Disease
- asthma
- Drug Name
- Symbicort
- Generic Name
- budesonide/formoterol
- Sponsor
- AstraZeneca
- Drug Status
- Approved Medicine
- Phase
- III
- Start Date
- Oct 22, 2004
- Study Name
- D5890L00007
- Study Id
- D5890L00007
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report Status
- Not Available
